H. Robert Brashear

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Reisa A. Sperling, Stephen Salloway, David J. Brooks et al. · The Lancet Neurology · 2012 · 497 citations · Full text

Alzheimer's Disease, Dementia, Retrospective Analysis +6

Cholinergic and GABAergic afferents to the olfactory bulb in the rat with special emphasis on the projection neurons in the nucleus of the horizontal limb of the diagonal band

László Záborszky, Jørn Carlsen, H. Robert Brashear et al. · The Journal of Comparative Neurology · 1986 · 385 citations

Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma

John Greenlee, H. Robert Brashear · Annals of Neurology · 1983 · 310 citations

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

Rik Vandenberghe, Juha O. Rinne, Merçé Boada et al. · Alzheimer s Research & Therapy · 2016 · 293 citations · Full text